nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—Coma—Vincristine—muscle cancer	0.0117	0.0117	CcSEcCtD
Tinidazole—Vaginal discharge—Methotrexate—muscle cancer	0.0103	0.0103	CcSEcCtD
Tinidazole—Candida infection—Etoposide—muscle cancer	0.00994	0.00994	CcSEcCtD
Tinidazole—Urine abnormality—Doxorubicin—muscle cancer	0.00975	0.00975	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.0094	0.0094	CcSEcCtD
Tinidazole—Urine analysis abnormal—Doxorubicin—muscle cancer	0.00918	0.00918	CcSEcCtD
Tinidazole—Burning sensation—Methotrexate—muscle cancer	0.00898	0.00898	CcSEcCtD
Tinidazole—Pelvic pain—Doxorubicin—muscle cancer	0.00888	0.00888	CcSEcCtD
Tinidazole—Vaginal discharge—Doxorubicin—muscle cancer	0.00888	0.00888	CcSEcCtD
Tinidazole—Ataxia—Vincristine—muscle cancer	0.00877	0.00877	CcSEcCtD
Tinidazole—Oral candidiasis—Doxorubicin—muscle cancer	0.0085	0.0085	CcSEcCtD
Tinidazole—Neutropenia—Dactinomycin—muscle cancer	0.00844	0.00844	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.0084	0.0084	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00798	0.00798	CcSEcCtD
Tinidazole—Stomatitis—Dactinomycin—muscle cancer	0.00784	0.00784	CcSEcCtD
Tinidazole—Burning sensation—Doxorubicin—muscle cancer	0.00777	0.00777	CcSEcCtD
Tinidazole—Dysuria—Vincristine—muscle cancer	0.00754	0.00754	CcSEcCtD
Tinidazole—Neutropenia—Vincristine—muscle cancer	0.00754	0.00754	CcSEcCtD
Tinidazole—Dermatitis atopic—Doxorubicin—muscle cancer	0.0073	0.0073	CcSEcCtD
Tinidazole—Pharyngitis—Dactinomycin—muscle cancer	0.00717	0.00717	CcSEcCtD
Tinidazole—Neuropathy peripheral—Vincristine—muscle cancer	0.00705	0.00705	CcSEcCtD
Tinidazole—Stomatitis—Vincristine—muscle cancer	0.00701	0.00701	CcSEcCtD
Tinidazole—Sweating—Vincristine—muscle cancer	0.00689	0.00689	CcSEcCtD
Tinidazole—Erythema multiforme—Dactinomycin—muscle cancer	0.00683	0.00683	CcSEcCtD
Tinidazole—Cramp muscle—Etoposide—muscle cancer	0.00681	0.00681	CcSEcCtD
Tinidazole—Glossitis—Methotrexate—muscle cancer	0.00677	0.00677	CcSEcCtD
Tinidazole—Flushing—Dactinomycin—muscle cancer	0.0067	0.0067	CcSEcCtD
Tinidazole—Bronchospasm—Etoposide—muscle cancer	0.00643	0.00643	CcSEcCtD
Tinidazole—Hypoaesthesia—Vincristine—muscle cancer	0.00642	0.00642	CcSEcCtD
Tinidazole—Urinary tract disorder—Vincristine—muscle cancer	0.00637	0.00637	CcSEcCtD
Tinidazole—Urethral disorder—Vincristine—muscle cancer	0.00633	0.00633	CcSEcCtD
Tinidazole—Neutropenia—Etoposide—muscle cancer	0.00611	0.00611	CcSEcCtD
Tinidazole—Glossitis—Doxorubicin—muscle cancer	0.00586	0.00586	CcSEcCtD
Tinidazole—Angiopathy—Vincristine—muscle cancer	0.00586	0.00586	CcSEcCtD
Tinidazole—Ill-defined disorder—Dactinomycin—muscle cancer	0.00584	0.00584	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00577	0.00577	CcSEcCtD
Tinidazole—Blood bilirubin increased—Doxorubicin—muscle cancer	0.00571	0.00571	CcSEcCtD
Tinidazole—Neuropathy peripheral—Etoposide—muscle cancer	0.00571	0.00571	CcSEcCtD
Tinidazole—Coma—Methotrexate—muscle cancer	0.0057	0.0057	CcSEcCtD
Tinidazole—Stomatitis—Etoposide—muscle cancer	0.00568	0.00568	CcSEcCtD
Tinidazole—Malaise—Dactinomycin—muscle cancer	0.00567	0.00567	CcSEcCtD
Tinidazole—Leukopenia—Dactinomycin—muscle cancer	0.00563	0.00563	CcSEcCtD
Tinidazole—Myalgia—Dactinomycin—muscle cancer	0.00535	0.00535	CcSEcCtD
Tinidazole—Discomfort—Dactinomycin—muscle cancer	0.00529	0.00529	CcSEcCtD
Tinidazole—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00524	0.00524	CcSEcCtD
Tinidazole—Hypoaesthesia—Etoposide—muscle cancer	0.0052	0.0052	CcSEcCtD
Tinidazole—Urinary tract disorder—Etoposide—muscle cancer	0.00516	0.00516	CcSEcCtD
Tinidazole—Candida infection—Doxorubicin—muscle cancer	0.00516	0.00516	CcSEcCtD
Tinidazole—Urethral disorder—Etoposide—muscle cancer	0.00513	0.00513	CcSEcCtD
Tinidazole—Blood urea increased—Doxorubicin—muscle cancer	0.0051	0.0051	CcSEcCtD
Tinidazole—Vertigo—Vincristine—muscle cancer	0.00505	0.00505	CcSEcCtD
Tinidazole—Leukopenia—Vincristine—muscle cancer	0.00503	0.00503	CcSEcCtD
Tinidazole—Thrombocytopenia—Dactinomycin—muscle cancer	0.00503	0.00503	CcSEcCtD
Tinidazole—Erythema multiforme—Etoposide—muscle cancer	0.00494	0.00494	CcSEcCtD
Tinidazole—Coma—Doxorubicin—muscle cancer	0.00493	0.00493	CcSEcCtD
Tinidazole—Anorexia—Dactinomycin—muscle cancer	0.00489	0.00489	CcSEcCtD
Tinidazole—Convulsion—Vincristine—muscle cancer	0.00487	0.00487	CcSEcCtD
Tinidazole—Flushing—Etoposide—muscle cancer	0.00485	0.00485	CcSEcCtD
Tinidazole—Myalgia—Vincristine—muscle cancer	0.00478	0.00478	CcSEcCtD
Tinidazole—Angiopathy—Etoposide—muscle cancer	0.00474	0.00474	CcSEcCtD
Tinidazole—Immune system disorder—Etoposide—muscle cancer	0.00472	0.00472	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00468	0.00468	CcSEcCtD
Tinidazole—Nervous system disorder—Vincristine—muscle cancer	0.0045	0.0045	CcSEcCtD
Tinidazole—Thrombocytopenia—Vincristine—muscle cancer	0.00449	0.00449	CcSEcCtD
Tinidazole—Decreased appetite—Dactinomycin—muscle cancer	0.00446	0.00446	CcSEcCtD
Tinidazole—Dysgeusia—Etoposide—muscle cancer	0.00446	0.00446	CcSEcCtD
Tinidazole—Hyperhidrosis—Vincristine—muscle cancer	0.00443	0.00443	CcSEcCtD
Tinidazole—Fatigue—Dactinomycin—muscle cancer	0.00443	0.00443	CcSEcCtD
Tinidazole—Muscle spasms—Etoposide—muscle cancer	0.00438	0.00438	CcSEcCtD
Tinidazole—Anorexia—Vincristine—muscle cancer	0.00437	0.00437	CcSEcCtD
Tinidazole—Ataxia—Methotrexate—muscle cancer	0.00426	0.00426	CcSEcCtD
Tinidazole—Feeling abnormal—Dactinomycin—muscle cancer	0.00423	0.00423	CcSEcCtD
Tinidazole—Ill-defined disorder—Etoposide—muscle cancer	0.00422	0.00422	CcSEcCtD
Tinidazole—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0042	0.0042	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00418	0.00418	CcSEcCtD
Tinidazole—Insomnia—Vincristine—muscle cancer	0.00415	0.00415	CcSEcCtD
Tinidazole—Paraesthesia—Vincristine—muscle cancer	0.00412	0.00412	CcSEcCtD
Tinidazole—Malaise—Etoposide—muscle cancer	0.0041	0.0041	CcSEcCtD
Tinidazole—Vertigo—Etoposide—muscle cancer	0.00409	0.00409	CcSEcCtD
Tinidazole—Leukopenia—Etoposide—muscle cancer	0.00407	0.00407	CcSEcCtD
Tinidazole—Abdominal pain—Dactinomycin—muscle cancer	0.00406	0.00406	CcSEcCtD
Tinidazole—Body temperature increased—Dactinomycin—muscle cancer	0.00406	0.00406	CcSEcCtD
Tinidazole—Decreased appetite—Vincristine—muscle cancer	0.00399	0.00399	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Vincristine—muscle cancer	0.00396	0.00396	CcSEcCtD
Tinidazole—Fatigue—Vincristine—muscle cancer	0.00395	0.00395	CcSEcCtD
Tinidazole—Convulsion—Etoposide—muscle cancer	0.00394	0.00394	CcSEcCtD
Tinidazole—Constipation—Vincristine—muscle cancer	0.00392	0.00392	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00385	0.00385	CcSEcCtD
Tinidazole—Discomfort—Etoposide—muscle cancer	0.00383	0.00383	CcSEcCtD
Tinidazole—Hypersensitivity—Dactinomycin—muscle cancer	0.00378	0.00378	CcSEcCtD
Tinidazole—Gastrointestinal pain—Vincristine—muscle cancer	0.00375	0.00375	CcSEcCtD
Tinidazole—Confusional state—Etoposide—muscle cancer	0.00375	0.00375	CcSEcCtD
Tinidazole—Ataxia—Doxorubicin—muscle cancer	0.00369	0.00369	CcSEcCtD
Tinidazole—Asthenia—Dactinomycin—muscle cancer	0.00368	0.00368	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—muscle cancer	0.00366	0.00366	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—muscle cancer	0.00366	0.00366	CcSEcCtD
Tinidazole—Thrombocytopenia—Etoposide—muscle cancer	0.00364	0.00364	CcSEcCtD
Tinidazole—Abdominal pain—Vincristine—muscle cancer	0.00363	0.00363	CcSEcCtD
Tinidazole—Body temperature increased—Vincristine—muscle cancer	0.00363	0.00363	CcSEcCtD
Tinidazole—Skin disorder—Etoposide—muscle cancer	0.00361	0.00361	CcSEcCtD
Tinidazole—Hyperhidrosis—Etoposide—muscle cancer	0.00359	0.00359	CcSEcCtD
Tinidazole—Anorexia—Etoposide—muscle cancer	0.00354	0.00354	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00353	0.00353	CcSEcCtD
Tinidazole—Diarrhoea—Dactinomycin—muscle cancer	0.00351	0.00351	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—muscle cancer	0.00349	0.00349	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00346	0.00346	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—muscle cancer	0.0034	0.0034	CcSEcCtD
Tinidazole—Hypersensitivity—Vincristine—muscle cancer	0.00338	0.00338	CcSEcCtD
Tinidazole—Sweating—Methotrexate—muscle cancer	0.00334	0.00334	CcSEcCtD
Tinidazole—Paraesthesia—Etoposide—muscle cancer	0.00334	0.00334	CcSEcCtD
Tinidazole—Dyspnoea—Etoposide—muscle cancer	0.00331	0.00331	CcSEcCtD
Tinidazole—Somnolence—Etoposide—muscle cancer	0.0033	0.0033	CcSEcCtD
Tinidazole—Asthenia—Vincristine—muscle cancer	0.00329	0.00329	CcSEcCtD
Tinidazole—Vomiting—Dactinomycin—muscle cancer	0.00326	0.00326	CcSEcCtD
Tinidazole—Rash—Dactinomycin—muscle cancer	0.00324	0.00324	CcSEcCtD
Tinidazole—Decreased appetite—Etoposide—muscle cancer	0.00323	0.00323	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Etoposide—muscle cancer	0.00321	0.00321	CcSEcCtD
Tinidazole—Fatigue—Etoposide—muscle cancer	0.0032	0.0032	CcSEcCtD
Tinidazole—Constipation—Etoposide—muscle cancer	0.00318	0.00318	CcSEcCtD
Tinidazole—Dysuria—Doxorubicin—muscle cancer	0.00317	0.00317	CcSEcCtD
Tinidazole—Neutropenia—Doxorubicin—muscle cancer	0.00317	0.00317	CcSEcCtD
Tinidazole—Diarrhoea—Vincristine—muscle cancer	0.00314	0.00314	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—muscle cancer	0.00311	0.00311	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—muscle cancer	0.00309	0.00309	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—muscle cancer	0.00307	0.00307	CcSEcCtD
Tinidazole—Feeling abnormal—Etoposide—muscle cancer	0.00306	0.00306	CcSEcCtD
Tinidazole—Nausea—Dactinomycin—muscle cancer	0.00305	0.00305	CcSEcCtD
Tinidazole—Gastrointestinal pain—Etoposide—muscle cancer	0.00304	0.00304	CcSEcCtD
Tinidazole—Dizziness—Vincristine—muscle cancer	0.00303	0.00303	CcSEcCtD
Tinidazole—Drowsiness—Doxorubicin—muscle cancer	0.00302	0.00302	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.003	0.003	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—muscle cancer	0.00296	0.00296	CcSEcCtD
Tinidazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00296	0.00296	CcSEcCtD
Tinidazole—Urticaria—Etoposide—muscle cancer	0.00295	0.00295	CcSEcCtD
Tinidazole—Stomatitis—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Tinidazole—Abdominal pain—Etoposide—muscle cancer	0.00294	0.00294	CcSEcCtD
Tinidazole—Body temperature increased—Etoposide—muscle cancer	0.00294	0.00294	CcSEcCtD
Tinidazole—Urinary tract infection—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Tinidazole—Vomiting—Vincristine—muscle cancer	0.00292	0.00292	CcSEcCtD
Tinidazole—Sweating—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Tinidazole—Rash—Vincristine—muscle cancer	0.00289	0.00289	CcSEcCtD
Tinidazole—Dermatitis—Vincristine—muscle cancer	0.00289	0.00289	CcSEcCtD
Tinidazole—Headache—Vincristine—muscle cancer	0.00287	0.00287	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—muscle cancer	0.00284	0.00284	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—muscle cancer	0.00283	0.00283	CcSEcCtD
Tinidazole—Hypersensitivity—Etoposide—muscle cancer	0.00274	0.00274	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—muscle cancer	0.00273	0.00273	CcSEcCtD
Tinidazole—Nausea—Vincristine—muscle cancer	0.00272	0.00272	CcSEcCtD
Tinidazole—Hypoaesthesia—Doxorubicin—muscle cancer	0.0027	0.0027	CcSEcCtD
Tinidazole—Pharyngitis—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Tinidazole—Urinary tract disorder—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Tinidazole—Asthenia—Etoposide—muscle cancer	0.00267	0.00267	CcSEcCtD
Tinidazole—Urethral disorder—Doxorubicin—muscle cancer	0.00266	0.00266	CcSEcCtD
Tinidazole—Pruritus—Etoposide—muscle cancer	0.00263	0.00263	CcSEcCtD
Tinidazole—Erythema multiforme—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Tinidazole—Diarrhoea—Etoposide—muscle cancer	0.00254	0.00254	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—muscle cancer	0.00253	0.00253	CcSEcCtD
Tinidazole—Flushing—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Tinidazole—Angiopathy—Doxorubicin—muscle cancer	0.00246	0.00246	CcSEcCtD
Tinidazole—Malaise—Methotrexate—muscle cancer	0.00246	0.00246	CcSEcCtD
Tinidazole—Dizziness—Etoposide—muscle cancer	0.00246	0.00246	CcSEcCtD
Tinidazole—Immune system disorder—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—muscle cancer	0.00236	0.00236	CcSEcCtD
Tinidazole—Vomiting—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Tinidazole—Malnutrition—Doxorubicin—muscle cancer	0.00236	0.00236	CcSEcCtD
Tinidazole—Rash—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Tinidazole—Dermatitis—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Tinidazole—Headache—Etoposide—muscle cancer	0.00233	0.00233	CcSEcCtD
Tinidazole—Flatulence—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Tinidazole—Dysgeusia—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—muscle cancer	0.00229	0.00229	CcSEcCtD
Tinidazole—Muscle spasms—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—muscle cancer	0.00224	0.00224	CcSEcCtD
Tinidazole—Nausea—Etoposide—muscle cancer	0.00221	0.00221	CcSEcCtD
Tinidazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—muscle cancer	0.00216	0.00216	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Tinidazole—Malaise—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Tinidazole—Vertigo—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Tinidazole—Leukopenia—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Tinidazole—Palpitations—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Tinidazole—Convulsion—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Tinidazole—Arthralgia—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Tinidazole—Myalgia—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—muscle cancer	0.002	0.002	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Tinidazole—Discomfort—Doxorubicin—muscle cancer	0.00199	0.00199	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Tinidazole—Confusional state—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00192	0.00192	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—muscle cancer	0.00192	0.00192	CcSEcCtD
Tinidazole—Nervous system disorder—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Tinidazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Tinidazole—Skin disorder—Doxorubicin—muscle cancer	0.00187	0.00187	CcSEcCtD
Tinidazole—Hyperhidrosis—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Tinidazole—Anorexia—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Tinidazole—Insomnia—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Tinidazole—Paraesthesia—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Tinidazole—Dyspnoea—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Tinidazole—Somnolence—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Tinidazole—Dyspepsia—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Tinidazole—Decreased appetite—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Tinidazole—Fatigue—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Tinidazole—Constipation—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Tinidazole—Feeling abnormal—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Tinidazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Tinidazole—Urticaria—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Tinidazole—Body temperature increased—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Tinidazole—Abdominal pain—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Tinidazole—Hypersensitivity—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Tinidazole—Rash—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Tinidazole—Headache—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Tinidazole—Asthenia—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Tinidazole—Pruritus—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Tinidazole—Nausea—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Tinidazole—Diarrhoea—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Tinidazole—Dizziness—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Tinidazole—Vomiting—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Tinidazole—Rash—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Tinidazole—Dermatitis—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Tinidazole—Headache—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Tinidazole—Nausea—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
